-+ 0.00%
-+ 0.00%
-+ 0.00%

ALPHA TAU RECEIVES FDA APPROVAL TO INITIATE A TRIAL FOR PATIENTS WITH LOCALLY RECURRENT PROSTATE CANCER

Reuters·12/02/2025 14:00:01

Please log in to view news